The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, biopharmaceutical and biotechnology companies to discuss the latest updates in the development of ADCs, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.

This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccine development and personalized immunotherapy.

Cerbrec exhibits at the conference, where we showcase our flagship product Graphbook. Our innovative platform enables researchers to seamlessly integrate AI models into their experiments through an intuitive point-and-click interface, unlocking new possibilities for scientific discoveries and advancements.